SMTL ID : 4o91.2 (1 other biounit)

Crystal Structure of type II inhibitor NG25 bound to TAK1-TAB1

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.39 Å

Oligo State

homo-tetramer

Ligands

4 x NG2: N-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-4-methyl-3-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)benzamide(Non-covalent)

NG2.1: 21 residues within 4Å: Chain A: V.24, A.35, I.36, K.37, E.51, Q.54, L.55, I.63, V.64, M.78, E.79, Y.80, A.81, L.118, I.127, H.128, L.137, I.147, C.148, D.149, F.150 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:V.24, A:A.35, A:E.51, A:L.55, A:V.64, A:M.78, A:L.137, A:D.149, A:F.150 Hydrogen bonds: A:E.51, A:A.81, A:A.81, A:D.149 Water bridges: A:Q.54 Salt bridges: A:D.149 Halogen bonds: A:I.147 NG2.2: 21 residues within 4Å: Chain B: V.24, A.35, I.36, K.37, E.51, Q.54, L.55, I.63, V.64, M.78, E.79, Y.80, A.81, L.118, I.127, H.128, L.137, I.147, C.148, D.149, F.150 16 PLIP interactions: 16 interactions with chain B Hydrophobic interactions: B:V.24, B:A.35, B:E.51, B:L.55, B:V.64, B:M.78, B:L.137, B:D.149, B:F.150 Hydrogen bonds: B:E.51, B:A.81, B:A.81, B:D.149 Water bridges: B:Q.54 Salt bridges: B:D.149 Halogen bonds: B:I.147 NG2.3: 21 residues within 4Å: Chain C: V.24, A.35, I.36, K.37, E.51, Q.54, L.55, I.63, V.64, M.78, E.79, Y.80, A.81, L.118, I.127, H.128, L.137, I.147, C.148, D.149, F.150 17 PLIP interactions: 17 interactions with chain C Hydrophobic interactions: C:V.24, C:A.35, C:E.51, C:L.55, C:V.64, C:M.78, C:L.137, C:D.149, C:F.150 Hydrogen bonds: C:E.51, C:E.51, C:A.81, C:A.81, C:D.149 Water bridges: C:Q.54 Salt bridges: C:D.149 Halogen bonds: C:I.147 NG2.4: 21 residues within 4Å: Chain D: V.24, A.35, I.36, K.37, E.51, Q.54, L.55, I.63, V.64, M.78, E.79, Y.80, A.81, L.118, I.127, H.128, L.137, I.147, C.148, D.149, F.150 17 PLIP interactions: 17 interactions with chain D Hydrophobic interactions: D:V.24, D:A.35, D:E.51, D:L.55, D:V.64, D:M.78, D:L.137, D:D.149, D:F.150 Hydrogen bonds: D:E.51, D:E.51, D:A.81, D:A.81, D:D.149 Water bridges: D:Q.54 Salt bridges: D:D.149 Halogen bonds: D:I.147

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tan, L. et al., Discovery of Type II Inhibitors of TGF beta-Activated Kinase 1 (TAK1) and Mitogen-Activated Protein Kinase Kinase Kinase Kinase 2 (MAP4K2). J.Med.Chem. (2015)

Release Date

2014-07-30

Peptides

Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

C
A

D
A

Mitogen-activated protein kinase kinase kinase 7/TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 chimera

Related Entries With Identical Sequence